Clinical Trials

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07478276 2026-03-17

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

84 enrolled

Treatment Adherence and Compliance, Lung Neoplasms, Motor Activity

NCT07478757 2026-03-17

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

15,000 enrolled

Lung Neoplasms

NCT07472478 2026-03-16

GIVEN

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07322341 2026-03-13

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

32 enrolled

Phase 4 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

106 enrolled

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

GastrointestinalGenitourinaryThoracic

430 enrolled

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07467005 2026-03-12

Video Double-Lumen Tube for Secondary Pulmonary Resection

500 enrolled

Lung Neoplasms

NCT07463677 2026-03-11

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

55 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07460440 2026-03-10

SPARC

240 enrolled

Lung Neoplasms

NCT07461662 2026-03-10

EBUS

204 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lung Neoplasms, Neoplasm Metastasis

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

94 enrolled

Lung Neoplasms

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

33 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

BreastGastrointestinalGynecologicThoracic

180 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07442890 2026-03-02

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

238 enrolled

Lung Neoplasms

NCT07432802 2026-02-27

STRADOS

182 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07434167 2026-02-25

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

30 enrolled

Lung Neoplasms

NCT07412041 2026-02-17

PERCC

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07412327 2026-02-17

A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

65 enrolled

Phase 1 Not yet recruiting

Lung Neoplasms

NCT07414953 2026-02-17

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

400 enrolled

Lung Neoplasms

NCT07401056 2026-02-12

READY-LUNG

62 enrolled